SCHEMBL4563103

SCHEMBL4563103

Cn1c(Nc2ccc(CC(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 14/20 0.82
RAF1 P04049 9/20 0.82
KDR P35968 4/20 0.82
LCK P06239 3/20 0.82
FYN P06241 3/20 0.82
PDGFRB P09619 3/20 0.82
KIT P10721 3/20 0.82
FLT1 P17948 3/20 0.82
FLT4 P35916 3/20 0.82
STK25 O00506 1/20 0.82
CIT O14578 1/20 0.82
EPHB6 O15197 1/20 0.82
MAP3K7 O43318 1/20 0.82
RIPK2 O43353 1/20 0.82
PAK3 O75914 1/20 0.82
STK10 O94804 1/20 0.82
MAP4K4 O95819 1/20 0.82
ABL1 P00519 1/20 0.82
CSF1R P07333 1/20 0.82
YES1 P07947 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1435201 0.93 BRAF (0.83) BRAFRAF1KDRLCKFYN
SCHEMBL11996499 0.90 BRAF (0.87) BRAFRAF1KDRLCKFYN
Raf-265 SCHEMBL29355586 0.90 BRAF (1.00) BRAFRAF1KDRLCKFYN
Raf-265 SCHEMBL1562237 0.90 BRAF (1.00) BRAFRAF1KDRLCKFYN
Raf-265 SCHEMBL29368571 0.90 BRAF (1.00) BRAFRAF1KDRLCKFYN
Raf-265 SCHEMBL686452 0.90 BRAF (1.00) BRAFRAF1KDRLCKFYN
SCHEMBL681128 0.90 BRAF (0.87) BRAFRAF1KDRLCKFYN
SCHEMBL1435161 0.89 BRAF (0.86) BRAFRAF1KDRLCKFYN
SCHEMBL12811765 0.89 BRAF (0.86) BRAFRAF1KDRLCKFYN
SCHEMBL1435427 0.89 BRAF (0.86) BRAFRAF1KDRLCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941462-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Achillion Pharmaceuticals, Inc. (US) 2022-01-26 EP disclosed
EP-2132198-A1 SOLID FORMS OF A RAF KINASE INHIBITOR Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008140850-A1 SOLID FORMS OF A RAF KINASE INHIBITOR NOVARTIS AG (CH) 2008-11-20 WO disclosed